Cargando…

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety

This review takes into consideration the principal vaccines developed against the SARS-CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of action of each vaccine as well as the efficacy, the safety and the storage temperature. In addition, the problem of the dose u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mascellino, Maria Teresa, Di Timoteo, Federica, De Angelis, Massimiliano, Oliva, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418359/ https://www.ncbi.nlm.nih.gov/pubmed/34511939 http://dx.doi.org/10.2147/IDR.S315727

Ejemplares similares

“Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter]
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection
por: Mascellino, Maria Teresa, et al.
Publicado: (2017)

Challenges in the Microbiological Diagnosis of Implant-Associated Infections: A Summary of the Current Knowledge
por: Oliva, Alessandra, et al.
Publicado: (2021)

Secondary Antibiotic Resistance, Correlation between Genotypic and Phenotypic Methods and Treatment in Helicobacter pylori Infected Patients: A Retrospective Study
por: Mascellino, Maria Teresa, et al.
Publicado: (2020)

Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19
por: Oliva, Alessandra, et al.
Publicado: (2021)

High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus
por: Oliva, Alessandra, et al.
Publicado: (2018)

Immunopathogenesis in Chlamydia trachomatis Infected Women
por: Mascellino, Maria Teresa, et al.
Publicado: (2011)

Editorial: Enterobacteriaceae Antimicrobial Agents and Resistance: Relationship With the Therapeutic Approach
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

Antibacterial Effectiveness of Fecal Water and In Vitro Activity of a Multi-Strain Probiotic Formulation against Multi-Drug Resistant Microorganisms
por: Oliva, Alessandra, et al.
Publicado: (2020)

Detection of Biofilm-associated Implant Pathogens in Cardiac Device Infections: High Sensitivity of Sonication Fluid Culture Even in the Presence of Antimicrobials
por: Oliva, Alessandra, et al.
Publicado: (2018)

Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview
por: Hadizadeh, Nastaran, et al.
Publicado: (2022)

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease
por: Nar, Herbert, et al.
Publicado: (2021)

High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii
por: De Angelis, Massimiliano, et al.
Publicado: (2022)

Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review
por: Toutoudaki, Konstantina, et al.
Publicado: (2023)

Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report
por: Oliva, Alessandra, et al.
Publicado: (2016)

The SARS-CoV-2 Vaccine Pipeline: an Overview
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational Study
por: Cancelli, F., et al.
Publicado: (2018)

An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2
por: Immordino, Palmira, et al.
Publicado: (2023)

An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition
por: Noske, Gabriela Dias, et al.
Publicado: (2023)

"ATLAS Overview and Main Results"
por: Sliwa, Krzysztof
Publicado: (2013)

ATLAS Overview and Main Results
por: Sliwa, K
Publicado: (2013)

ATLAS overview and main results
por: Sliwa, K
Publicado: (2013)

Helicobacter pylori: Determinant and Markers of Virulence
por: Mascellino, M. T., et al.
Publicado: (2009)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
por: Al-Sehemi, Abdullah G., et al.
Publicado: (2022)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
por: Chebel, Roy, et al.
Publicado: (2021)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

SARS-CoV-2 Vaccine Development: An Overview and Perspectives
por: Liu, Yi, et al.
Publicado: (2020)

Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
por: Shiravi, Amir Abbas, et al.
Publicado: (2021)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection
por: Cuomo, Gianluca, et al.
Publicado: (2020)

Role of Serum E-Selectin as a Biomarker of Infection Severity in Coronavirus Disease 2019
por: Oliva, Alessandra, et al.
Publicado: (2021)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
por: Fuzimoto, Andréa D.
Publicado: (2021)

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
por: Pilz, Stefan, et al.
Publicado: (2022)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
por: Ram, Thrigulla Saketh, et al.
Publicado: (2022)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

The ATLAS experiment: overview and main results.
por: Stroynowski, R
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p9949988ls3ebtuqccfarons8m